Form CERT - Certification by an exchange approving securities for listing:
SEC Accession No. 0001354457-21-000669
Filing Date
2021-06-16
Accepted
2021-06-16 11:42:18
Documents
1
Effectiveness Date
2021-06-16

Document Format Files

Seq Description Document Type Size
1 8A_Cert_LYEL.pdf CERT 227137
  Complete submission text file 0001354457-21-000669.txt   310843
Mailing Address 400 EAST JAMIE COURT SUITE 301 SOUTH SAN FRANCISCO CA 94080
Business Address 400 EAST JAMIE COURT SUITE 301 SOUTH SAN FRANCISCO CA 94080 650 695-0677
Lyell Immunopharma, Inc. (Filer) CIK: 0001806952 (see all company filings)

EIN.: 833006753 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CERT | Act: 34 | File No.: 001-40502 | Film No.: 211020837
SIC: 2834 Pharmaceutical Preparations